Publications by authors named "Andrew Lenis"

Claim this Profile
R
Revisiting BCG: The potential of rescue BCG therapy for BCG-unresponsive non-muscle-invasive bladder cancer.
Ketty Bai, Srinath-Reddi Pingle, Rainjade Chung, Benjamin I Joffe, Caroline Laplaca, Andrew T Lenis

Urol Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Daniel L Ranti, Andrew T Lenis

J Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.
Carissa E Chu, Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T Lenis

Eur Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidental Bladder Lesions on Prostate Multiparametric MRI: Prevalence and Factors Associated with Bladder Carcinoma.
Siddhant Dogra, Joshua Lee, Mutita Siriruchatanon, Zehui Gu, Chenchan Huang, Andrew Lenis

Acad Radiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the : Is Prostate MRI an Oncologically Safe Tool for Avoiding Biopsy?
Hiram Shaish, Andrew Lenis

AJR Am J Roentgenol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations.
Benjamin I Joffe, John R Christin, Clémentine Le Coz, Prakash Gorroochurn, Jamie S Pak, Andrew T Lenis

Urol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Molecular, Pathological, and Clinical Characterization of Clear Cell Adenocarcinoma of the Urinary Tract.
Rayan Rammal, Florestan J Koll, Ziyu Chen, Jacob E Tallman, Syed Muneeb Alam, Andrew T Lenis

Mod Pathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.
Manuel R De Jesus Escano, Emily A Vertosick, Neeta D'Souza, Nicole Benfante, Andrew T Lenis

Urol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Srinath-Reddi Pingle, Andrew T Lenis

J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance.
Benjamin I Joffe, John R Christin, Clémentine Le Coz, Srinath-Reddi Pingle, Alexander Z Wei, Andrew T Lenis

Curr Urol Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.
Kwanghee Kim, Syed M Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew T Lenis

Eur Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of indocyanine green on partial nephrectomy perioperative outcomes.
Benjamin I Joffe, Gen Li, Prakash Gorroochurn, Guarionex Joel DeCastro, Andrew T Lenis

J Robot Surg· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor characteristics in immunosuppressed and renal dysfunction populations.
Benjamin I Joffe, Luis Pina Martina, Mason Stillman, Dylan Rust, Prakash Gorroochurn, Andrew T Lenis

Urol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer.
Justin W Ingram, Rainjade Chung, Caroline Laplaca, James M McKiernan, Andrew T Lenis

Urol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.
Andrew T Lenis, Vignesh Ravichandran, Samantha Brown, Syed M Alam, Andrew Katims

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer.
Andrew T Lenis, Karissa Whiting, Vignesh Ravichandran, Jacob E Tallman, Syed M Alam

JCO Precis Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Benjamin I Joffe, Andrew T Lenis

Urol Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience.
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Duzgol, Andrew T Lenis

Clin Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcomes in patients with muscle invasive bladder cancer undergoing radical vs. partial cystectomy.
Rainjade Chung, George W Moran, Miyad Movassaghi, Daniel Pohl, Justin Ingram, Andrew T Lenis

Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readmissions after radical nephrectomy in a national cohort.
Joaquin Michel, Dhaval Jivanji, Alexander N Goel, Patrick M Lec, Andrew T Lenis

Scand J Urol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Hong Truong, Kelsey Breen, Subhiksha Nandakumar, Daniel D Sjoberg, Yelena Kemel, Andrew T Lenis

Eur Urol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.
Timothy N Clinton, Ziyu Chen, Hannah Wise, Andrew T Lenis, Shweta Chavan

Cell Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Andrew T Lenis

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Joshua I Warrick, Wenhuo Hu, Hironobu Yamashita, Vonn Walter, Lauren Shuman, Andrew T Lenis

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma.
Andrew B Katims, Peter A Reisz, Lucas Nogueira, Hong Truong, Andrew T Lenis

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis